NuCana plc
NCNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709626
No open-market purchases or sales by NuCana plc insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $167.9K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in NuCana plc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −7 vs. Q4 2024
- Shares held
- 270.5K
- −177.8K (−39.7%) vs. Q4 2024
- Total value
- $238.2K
- −$293.8K (−55.2%) vs. Q4 2024
- New holders
- 3
- 1 more added
- Sold out
- 10
- 3 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NCNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $167.9K |
| Q1 2026 | 8 | $79.5K |
| Q4 2025 | 9 | $643.4K |
| Q3 2025 | 10 | $835.6K |
| Q2 2025 | 17 | $38.8K |
| Q1 2025 | 12 | $238.2K |
| Q4 2024 | 20 | $532.0K |
| Q3 2024 | 18 | $589.9K |
| Q2 2024 | 15 | $866.6K |
| Q1 2024 | 23 | $2.05M |
| Q4 2023 | 24 | $3.89M |
| Q3 2023 | 21 | $8.34M |
| Q2 2023 | 21 | $10.8M |
| Q1 2023 | 25 | $13.2M |
| Q4 2022 | 27 | $9.18M |
| Q3 2022 | 28 | $14.7M |
| Q2 2022 | 26 | $10.0M |
| Q1 2022 | 34 | $15.0M |
| Q4 2021 | 38 | $44.7M |
| Q3 2021 | 31 | $47.5M |
| Q2 2021 | 33 | $58.7M |
| Q1 2021 | 35 | $129.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding NuCana plc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carlyle Group Inc. | 133,333 | $116.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 44,772 | $39.1K | 0.00% | −300−0.7% | Reduced |
| Acadian Asset Management LLC | 38,321 | $33.0K | 0.00% | −4,094−9.7% | Reduced |
| Glass Jacobson Investment Advisors llc | 15,000 | $17.9K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 20,157 | $17.6K | 0.00% | +20,157 | New |
| Baader Bank INC | 10,031 | $6.92K | 0.00% | +10,031 | New |
| Citigroup Inc | 5,560 | $4.85K | 0.00% | +5,560 | New |
| Rhumbline Advisers | 1,822 | $1.59K | 0.00% | +477+35.5% | Added |
| GAMMA Investing LLC | 1,213 | $1.06K | 0.00% | −16,502−93.2% | Reduced |
| AllSquare Wealth Management LLC | 205 | $179 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 68 | $59 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6 | $5 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −46,722−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −40,399−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −36,704−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −25,003−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,986−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −12,313−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −8,913−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |